Novel Treatments for Adolescent Vaping Cessation: Are We There Yet?
E-cigarette use among adolescents is a growing public health concern, driven by discreet designs, appealing flavors, and social influences. Despite high addiction rates, most teen users express a desire to quit, though evidence-based cessation tools remain limited. Behavioral interventions, including tech-based programs like <i>This Is Quitting</i> and <i>smokeSCREEN</i>, show promise. Pharmacotherapy, particularly varenicline, may support quitting, though its role in adolescents is still under investigation. Pediatricians must address this issue through empathetic, multifaceted approaches that combine education, behavioral support, and emerging treatments to curb early nicotine dependence and its long-term health consequences.
Authors
- Zouina Sarfraz (ORCID: https://orcid.org/0000-0002-5132-7455)
- Lakshit Jain (ORCID: https://orcid.org/0000-0003-3080-9356)
- Mohsin Raza (ORCID: https://orcid.org/0000-0002-4530-5030)
- Jasleen Kaur (ORCID: https://orcid.org/0000-0002-0584-4638)
- Amanda Rossi
- S. Keith Adams (ORCID: https://orcid.org/0009-0005-0125-8833)
- Mariginder Singh Varowal
Institutions
- Hartford Hospital (US)
- Fatima Jinnah Medical University (PK)
- Government Medical College, Amritsar (IN)
- Connecticut Valley Hospital (US)
- New Haven Family Alliance (US)
- ILC Dover (United States) (US)
- UConn Health (US)
Publication Details
- Journal
- Journal of Community Hospital Internal Medicine Perspectives
- Published
- 2025-09-12
- DOI
- https://doi.org/10.55729/2000-9666.1526
- Primary Topic
- Sexuality, Behavior, and Technology
- Type
- article
- Field-Weighted Citation Impact
- 0.00